Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis
NCT03397979 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63
Last updated 2018-01-12
Summary
There are few studies evaluating best bathing practices in the management of pediatric atopic dermatitis (AD). Trans-epidermal water loss plays a key role in the pathophysiology of AD. In concert with application of topical corticosteroids (TCS), we sought to investigate whether frequent soaking baths (i.e. twice daily for two weeks), followed immediately by application of an occlusive moisturizer (i.e. soak-and-seal), would be more effective than infrequent soaking baths (i.e. twice weekly for two weeks) in the management of AD.
Conditions
Interventions
- BEHAVIORAL
-
Infrequent versus Frequent Soaking Baths
Submersion of skin, affected by atopic dermatitis, in a bathtub filled with luke-warm water, where the frequency and duration of these baths are varied, to look for any differential effect.
Sponsors & Collaborators
-
MaineHealth
lead OTHER
Principal Investigators
-
Ivan D Cardona, M.D. · Allergy & Asthma Associates of Maine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 6 Months
- Max Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-11-14
- Primary Completion
- 2016-04-07
- Completion
- 2017-03-21
Countries
- United States
Study Locations
More Related Trials
-
A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families
NCT02067234 ·Status: WITHDRAWN ·Phase: NA
-
Atopic Dermatitis in Atopy Predisposed Infants
NCT02906475 ·Status: COMPLETED ·Phase: NA
-
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
NCT03981926 ·Status: COMPLETED ·Phase: NA
-
Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis
NCT03559075 ·Status: COMPLETED
-
Efficacy of Topical Coal Tar in Children With Atopic Dermatitis
NCT03461302 ·Status: UNKNOWN ·Phase: PHASE4
-
Internet-based Mindfulness and Exposure Treatment for Atopic Dermatitis
NCT03051958 ·Status: COMPLETED ·Phase: NA
-
A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
NCT02634905 ·Status: TERMINATED ·Phase: NA
-
A Study of a Moisturizing Cream and Baby Wash in the Management of Mild to Moderate Atopic Dermatitis in Infants, Toddlers and Children
NCT04740892 ·Status: COMPLETED ·Phase: NA
-
Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients
NCT06983561 ·Status: COMPLETED
-
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
NCT06461897 ·Status: RECRUITING ·Phase: PHASE3
-
Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.
NCT05575882 ·Status: RECRUITING ·Phase: NA
-
A Tolerability Assessment Study of Three Wash Products in Infants
NCT02403999 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
NCT03345914 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis
NCT00919763 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children
NCT00886587 ·Status: COMPLETED ·Phase: NA
-
Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis
NCT02589392 ·Status: COMPLETED ·Phase: NA
-
Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence
NCT02193230 ·Status: COMPLETED
-
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
NCT05042258 ·Status: RECRUITING ·Phase: PHASE4
-
HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers
NCT05611346 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03568318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis
NCT03775590 ·Status: TERMINATED ·Phase: NA
-
Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis
NCT01996423 ·Status: COMPLETED ·Phase: NA
-
Text Messaging and Atopic Dermatitis
NCT01216059 ·Status: COMPLETED ·Phase: NA
-
A Community-based Assessment of Skin Care, Allergies, and Eczema
NCT03409367 ·Status: COMPLETED ·Phase: NA
-
Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema
NCT01326910 ·Status: COMPLETED ·Phase: NA